Status:
RECRUITING
Boosting Emotional Well-being and Happiness in Outpatients Living With Diabetes
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The focus of this study is to test the efficacy of an 8-week, remotely delivered, positive-psychology-motivational interviewing (PP-MI) intervention, with additional twice weekly text messages for a t...
Detailed Description
The investigators are proposing a study that will focus on testing the efficacy of a PP-MI intervention, with additional twice text messages for a total of 16 weeks (with interactive, algorithm-driven...
Eligibility Criteria
Inclusion
- Diagnosis of Type 2 Diabetes
- Low physical activity (\<150 minutes/week of moderate to vigorous physical activity)
Exclusion
- Cognitive deficits impeding a participant's ability to provide informed consent or participate
- Medical conditions likely to lead to death within 6 months.
- Pre-existing coronary artery disease
- Moderate-severe depression (Patient Health Questionnaire-9 \[PHQ-9\] score ≥15)
- Use of non-basal insulin
- Inability to participate in physical activity due to another medical condition
- Inability to receive text messages
- Inability to read, write, or speak in English
- Current participation in another intervention or program that has been designed to promote well-being or physical activity
Key Trial Info
Start Date :
October 12 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2026
Estimated Enrollment :
280 Patients enrolled
Trial Details
Trial ID
NCT05420051
Start Date
October 12 2022
End Date
September 30 2026
Last Update
April 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114